HealthTech firm InventionMed plans to move to WSE main market
22:38
Health tech company InventionMed wants to move its shares to the WSE main market in 2018/2019, the firm’s CEO Tomasz Kierul told ISBnews. The company has no plans for another shares issue, as it has sufficient funds for its current projects and will also apply for EU grants for R&D investments, the CEO stated. InventionMed produces AR/VR medical simulators. According to Kierul, the market for VR and AR technology in medicine is growing at a rate of 29 percent annually. The company was launched in January 2018 and is currently listed on NewConnect.
